Assessing the landscape of ovarian serous borderline tumors

被引:9
|
作者
Messini, Irini [1 ]
Doulgeraki, Triada [1 ]
Chrysanthakis, Dimitris [1 ]
Yiannou, Petros [1 ]
Gavresea, Theofani [1 ]
Papadimitriou, Christos [2 ]
Panoskaltsis, Theodoros [3 ]
Voulgaris, Zannis [4 ]
Vlachos, Athanassios [4 ]
Pavlakis, Kitty [1 ,5 ]
机构
[1] IASO Womens Hosp, Pathol Dept, Maroussi 15123, Greece
[2] Univ Athens, Aretaie Hosp, Dept Surg 2, Oncol Unit, Athens, Greece
[3] Univ Athens, Aretaie Hosp, Acad Dept Obstet & Gynecol 2, Athens, Greece
[4] IASO Womens Hosp, Dept Gynecol Oncol, Maroussi, Greece
[5] Univ Athens, Pathol Dept 1, Athens, Greece
关键词
LYMPH-NODE INVOLVEMENT; DIAGNOSTIC-CRITERIA; ENDOSALPINGIOSIS; CLASSIFICATION; CARCINOMAS; PATHOLOGY; PROGNOSIS; IMPLANTS; IMPACT;
D O I
10.1136/ijgc-2018-000086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim To compare distinct clinicopathological features between atypical proliferative serous tumors and non-invasive low-grade ovarian serous carcinomas. Methods Our study group comprised 203 cases of serous borderline tumors sub-classified as atypical proliferative serous tumors or as non-invasive low-grade serous carcinomas. All pathological features related to borderline tumors were re-evaluated by two gynecological pathologists. Data concerning recurrences and survival were retrieved from the medical records of the patients. Results When comparing atypical proliferative serous tumors to non-invasive low-grade serous carcinomas, the latter were statistically related to advanced stage at diagnosis, bilateral disease, exophytic pattern of growth, microinvasive carcinoma, and the presence of invasive implants. In univariate analysis, recurrences were statistically related to the exophytic pattern of growth, to microinvasion, and to the presence of implants (both invasive and non-invasive). Nevertheless, in multivariate analysis, only microinvasion and the presence of invasive implants were related to recurrence. Women who eventually succumbed to the disease were only those with invasive implants. Their ovarian tumor was either a non-invasive low-grade serous carcinoma or an atypical proliferative serous tumor with 'minimal' micropapillary pattern. Neither lymph node involvement nor endosalpingiosis seemed to influence the course of the disease. Conclusions The results of our study underline the increased possibility of non-invasive low-grade serous carcinomas to be related with features indicative of aggressive behavior as opposed to atypical proliferative serous tumors. Nevertheless, irrespective of tumor histology, the presence of invasive implants and microinvasion were the only independent prognostications of recurrence.
引用
收藏
页码:572 / 578
页数:7
相关论文
共 50 条
  • [1] MORPHOLOGY OF OVARIAN SEROUS BORDERLINE TUMORS
    KARSELADZE, AI
    [J]. ARKHIV PATOLOGII, 1989, 51 (03) : 28 - 34
  • [2] Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer
    Krishnan, Rahul
    Bilecz, Agnes
    Herbst, Paula
    Shimizu, Aasa
    Schweizer, Lisa
    Jaeger, Ellen
    Godden, Jen
    Stoppler, Melissa
    Yamada, Diane
    Lengyel, Ernst
    [J]. CANCER RESEARCH, 2024, 84 (05)
  • [3] RECURRENCES IN OVARIAN SEROUS BORDERLINE TUMORS (SBT)
    STEINMETZ, JC
    SILVA, EG
    ELNAGGAR, A
    GERSHENSON, DW
    [J]. LABORATORY INVESTIGATION, 1990, 62 (01) : A95 - A95
  • [4] Ovarian serous borderline tumors: The Citadel defended
    Kurman, RJ
    Seidman, JD
    [J]. HUMAN PATHOLOGY, 2000, 31 (11) : 1439 - 1440
  • [5] THE CHARACTERISTICS OF OVARIAN SEROUS TUMORS OF BORDERLINE MALIGNANCY
    唐敏一
    连利娟
    刘彤华
    [J]. 中华医学杂志(英文版), 1980, (07) : 459 - 464
  • [6] Ovarian serous borderline tumors: The citadel defended
    Kempson, RL
    Hendrickson, MR
    [J]. HUMAN PATHOLOGY, 2000, 31 (05) : 525 - 526
  • [7] The molecular pathology of ovarian serous borderline tumors
    Malpica, A.
    Wong, K. -K.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 16 - 19
  • [8] THE CHARACTERISTICS OF OVARIAN SEROUS TUMORS OF BORDERLINE MALIGNANCY
    TANG, MY
    LIAN, LJ
    LIU, TH
    [J]. CHINESE MEDICAL JOURNAL, 1980, 93 (07) : 459 - 464
  • [9] CD 56 expression in serous invasive ovarian cancer and serous ovarian borderline tumors
    Pokieser, W.
    Hauptmann, S.
    [J]. VIRCHOWS ARCHIV, 2010, 457 (02) : 151 - 151
  • [10] Ovarian serous borderline tumors with invasive peritoneal implants
    Gershenson, DM
    Silva, EG
    Levy, L
    Burke, TW
    Wolf, JK
    Tornos, C
    [J]. CANCER, 1998, 82 (06) : 1096 - 1103